CervoMed Inc. Depreciation
CervoMed Inc. (CRVO) reported Depreciation of $0 for the 9-month period ending 2022-09-30, per its 10-Q filed 2022-11-14.
Discontinued › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2022-11-14
- CervoMed Inc. depreciation for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. depreciation for the quarter ending 2022-06-30 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. depreciation for the quarter ending 2022-03-31 was $0.00, a 100.00% decline year-over-year.
- CervoMed Inc. depreciation for the quarter ending 2021-09-30 was $19.10K, a 21.05% decline year-over-year.
- CervoMed Inc. depreciation for fiscal 2020 was $103.17K, a 5.36% increase from fiscal 2019.
- CervoMed Inc. depreciation for fiscal 2019 was $97.92K, a 11.29% decline from fiscal 2018.
- CervoMed Inc. depreciation for fiscal 2018 was $110.37K, a 62.36% increase from fiscal 2017.
- CervoMed Inc. depreciation for fiscal 2017 was $67.98K, a 168.25% increase from fiscal 2016.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 9 month as first filed | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $0.00 derived: sum of 2 quarters · filed 2022-11-14 | $0.00 10-Q · filed 2022-11-14 | |||||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $0.00 10-Q · filed 2022-08-12 | ||||||
| 2022-03-31 | $0.00 10-Q · filed 2022-05-12 | |||||||
| 2021-09-30 | $19.10K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $42.85K derived: sum of 2 quarters · filed 2022-11-14 | $67.30K 10-Q · filed 2022-11-14 | $92.24K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | $23.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $48.20K 10-Q · filed 2022-08-12 | $73.14K derived: sum of 3 quarters · filed 2022-08-12 | $97.33K derived: sum of 4 quarters · filed 2022-08-12 | ||||
| 2021-03-31 | $24.45K 10-Q · filed 2022-05-12 | $49.38K derived: sum of 2 quarters · filed 2022-05-12 | $73.57K derived: sum of 3 quarters · filed 2022-05-12 | $100.59K derived: sum of 4 quarters · filed 2022-05-12 | ||||
| 2020-12-31 | $24.93K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $49.13K derived: sum of 2 quarters · filed 2021-11-10 | $76.15K derived: sum of 3 quarters · filed 2021-11-10 | $103.17K 10-K · filed 2021-03-17 | ||||
| 2020-09-30 | $24.19K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $51.21K derived: sum of 2 quarters · filed 2021-11-10 | $78.23K 10-Q · filed 2021-11-10 | $105.31K derived: sum of 4 quarters · filed 2021-11-10 | ||||
| 2020-06-30 | $27.02K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $54.04K 10-Q · filed 2021-08-11 | $81.12K derived: sum of 3 quarters · filed 2021-08-11 | $99.29K derived: sum of 4 quarters · filed 2021-08-11 | ||||
| 2020-03-31 | $27.02K 10-Q · filed 2021-05-07 | $54.09K derived: sum of 2 quarters · filed 2021-05-07 | $72.27K derived: sum of 3 quarters · filed 2021-05-07 | $106.66K derived: sum of 4 quarters · filed 2021-05-07 | ||||
| 2019-12-31 | $27.07K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-17 | $45.25K derived: sum of 2 quarters · filed 2021-03-17 | $79.64K derived: sum of 3 quarters · filed 2021-03-17 | $97.92K 10-K · filed 2021-03-17 | ||||
| 2019-09-30 | $18.18K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | $52.57K derived: sum of 2 quarters · filed 2020-11-12 | $70.84K 10-Q · filed 2020-11-12 | $99.76K derived: sum of 4 quarters · filed 2020-11-12 | ||||
| 2019-06-30 | $34.39K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $52.66K 10-Q · filed 2020-08-07 | $81.58K derived: sum of 3 quarters · filed 2020-08-07 | $108.31K derived: sum of 4 quarters · filed 2020-08-07 | ||||
| 2019-03-31 | $18.27K 10-Q · filed 2020-05-11 | $47.19K derived: sum of 2 quarters · filed 2020-05-11 | $73.92K derived: sum of 3 quarters · filed 2020-05-11 | $100.63K derived: sum of 4 quarters · filed 2020-05-11 | ||||
| 2018-12-31 | $28.92K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-17 | $55.64K derived: sum of 2 quarters · filed 2020-03-17 | $82.35K derived: sum of 3 quarters · filed 2020-03-17 | $110.37K 10-K · filed 2020-03-17 | ||||
| 2018-09-30 | $26.72K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $53.43K derived: sum of 2 quarters · filed 2019-11-08 | $81.45K 10-Q · filed 2019-11-08 | $109.66K derived: sum of 4 quarters · filed 2019-11-08 | ||||
| 2018-06-30 | $26.71K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-08 | $54.73K 10-Q · filed 2019-08-08 | $82.94K derived: sum of 3 quarters · filed 2019-08-08 | $110.31K derived: sum of 4 quarters · filed 2019-08-08 | ||||
| 2018-03-31 | $28.02K 10-Q · filed 2019-05-09 | $56.23K derived: sum of 2 quarters · filed 2019-05-09 | $83.61K derived: sum of 3 quarters · filed 2019-05-09 | $89.40K derived: sum of 4 quarters · filed 2019-05-09 | ||||
| 2017-12-31 | $28.21K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-19 | $55.59K derived: sum of 2 quarters · filed 2019-03-19 | $61.38K derived: sum of 3 quarters · filed 2019-03-19 | $67.98K 10-K · filed 2019-03-19 | ||||
| 2017-09-30 | $27.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-13 | $33.16K derived: sum of 2 quarters · filed 2018-11-13 | $39.77K 10-Q · filed 2018-11-13 | $45.59K derived: sum of 4 quarters · filed 2018-11-13 | ||||
| 2017-06-30 | $5.79K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-10 | $12.39K 10-Q · filed 2018-08-10 | $18.21K derived: sum of 3 quarters · filed 2018-08-10 | |||||
| 2017-03-31 | $6.60K 10-Q · filed 2018-05-10 | $12.43K derived: sum of 2 quarters · filed 2018-05-10 | ||||||
| 2016-12-31 | $5.82K derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | $25.34K 10-K · filed 2018-04-02 | $25.00K 10-K · filed 2017-03-31 | |||||
| 2016-09-30 | $19.52K 10-Q · filed 2017-11-13 | |||||||
| 2015-12-31 | -$9.88K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-31 | -$4.48K derived: sum of 2 quarters · filed 2017-03-31 | $1.72K derived: sum of 3 quarters · filed 2017-03-31 | $8.00K 10-K · filed 2017-03-31 | $23.27K 10-K · filed 2016-03-25 | |||
| 2015-09-30 | $5.39K 10-Q · filed 2015-11-12 | $11.59K derived: sum of 2 quarters · filed 2015-11-12 | $17.88K 10-Q · filed 2015-11-12 | |||||
| 2015-06-30 | $6.20K 10-Q · filed 2015-08-12 | $12.48K 10-Q · filed 2015-08-12 | ||||||
| 2014-12-31 | $2.95K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-25 | $4.86K derived: sum of 2 quarters · filed 2016-03-25 | $7.41K derived: sum of 3 quarters · filed 2016-03-25 | $11.92K 10-K · filed 2016-03-25 | ||||
| 2014-09-30 | $1.91K 10-Q · filed 2015-11-12 | $4.46K derived: sum of 2 quarters · filed 2015-11-12 | $8.97K 10-Q · filed 2015-11-12 | $3.77K 10-Q · filed 2014-11-12 | $25.31K derived: sum of 4 quarters · filed 2015-11-12 | |||
| 2014-06-30 | $2.56K 10-Q · filed 2015-08-12 | $395.00 10-Q · filed 2014-08-14 | $7.07K 10-Q · filed 2015-08-12 | $2.56K 10-Q · filed 2014-08-14 | $23.41K derived: sum of 3 quarters · filed 2015-08-12 | $30.89K derived: sum of 4 quarters · filed 2015-08-12 | ||
| 2014-03-31 | $4.51K 10-Q · filed 2014-05-20 | $20.85K derived: sum of 2 quarters · filed 2015-04-03 | $28.33K derived: sum of 3 quarters · filed 2015-04-03 | $36.28K derived: sum of 4 quarters · filed 2015-04-03 | ||||
| 2013-12-31 | $16.34K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-03 | $23.82K derived: sum of 2 quarters · filed 2015-04-03 | $31.77K derived: sum of 3 quarters · filed 2015-04-03 | $40.92K 10-K · filed 2015-04-03 | ||||
| 2013-09-30 | $7.48K 10-Q · filed 2014-11-12 | $15.43K derived: sum of 2 quarters · filed 2014-11-12 | $24.58K 10-Q · filed 2014-11-12 | $21.27K derived: sum of 4 quarters · filed 2014-11-12 | ||||
| 2013-06-30 | $7.95K 10-Q · filed 2014-08-14 | $17.10K 10-Q · filed 2014-08-14 | $13.79K derived: sum of 3 quarters · filed 2014-08-14 | $23.65K derived: sum of 4 quarters · filed 2014-08-14 | ||||
| 2013-03-31 | $8.69K 10-Q · filed 2014-05-20 | $9.15K 10-Q/A · filed 2013-05-20 | $5.84K derived: sum of 2 quarters · filed 2014-05-20 | $15.70K derived: sum of 3 quarters · filed 2014-05-20 | $25.58K derived: sum of 4 quarters · filed 2014-05-20 | |||
| 2012-12-31 | -$2.84K derived: 10-K/A 12 month − 10-Q 9 month · filed 2014-04-23 | $7.01K derived: sum of 2 quarters · filed 2014-04-23 | $16.89K derived: sum of 3 quarters · filed 2014-04-23 | $26.77K 10-K/A · filed 2014-04-23 | $34.04K 10-K/A · filed 2013-04-24 | |||
| 2012-09-30 | $9.86K 10-Q · filed 2013-11-19 | $8.00K 10-Q · filed 2012-11-19 | $19.73K derived: sum of 2 quarters · filed 2013-11-19 | $29.61K 10-Q · filed 2013-11-19 | $19.76K 10-Q · filed 2012-11-19 | $145.36K derived: sum of 4 quarters · filed 2013-11-19 | ||
| 2012-06-30 | $9.88K 10-Q · filed 2013-08-14 | $19.76K 10-Q · filed 2013-08-14 | $135.51K derived: sum of 3 quarters · filed 2013-08-14 | $145.97K derived: sum of 4 quarters · filed 2013-08-14 | ||||
| 2012-03-31 | $9.88K 10-Q/A · filed 2013-05-20 | $125.63K derived: sum of 2 quarters · filed 2013-05-20 | $136.09K derived: sum of 3 quarters · filed 2013-05-20 | |||||
| 2011-12-31 | $115.75K derived: 10-K/A 12 month − 10-Q 9 month · filed 2013-04-24 | $126.21K derived: sum of 2 quarters · filed 2013-04-24 | $119.81K 10-K/A · filed 2013-04-24 | |||||
| 2011-09-30 | $10.46K 10-Q · filed 2012-11-19 | $4.05K 10-Q · filed 2012-11-19 | ||||||
| 2011-06-30 | $4.05K 10-Q/A · filed 2012-09-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |